Pesquisas alternativas:
small compared » small companies (Expandir a Pesquisa), recall compared (Expandir a Pesquisa), small compound (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
gel compared » model compared (Expandir a Pesquisa), level compared (Expandir a Pesquisa), tool compared (Expandir a Pesquisa)
compared can » compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa), compared cases (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
3 gel » _ gel (Expandir a Pesquisa), i gel (Expandir a Pesquisa), a gel (Expandir a Pesquisa)
small compared » small companies (Expandir a Pesquisa), recall compared (Expandir a Pesquisa), small compound (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
gel compared » model compared (Expandir a Pesquisa), level compared (Expandir a Pesquisa), tool compared (Expandir a Pesquisa)
compared can » compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa), compared cases (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
3 gel » _ gel (Expandir a Pesquisa), i gel (Expandir a Pesquisa), a gel (Expandir a Pesquisa)
1
Publicado no Mol Cell Proteomics
(2017)
“... by the following grants: 1U19AI091175-05 NIH/NIAID; 5P30CA013696-39S3 NIH/NCI; 2U19AI067773-11 NIH/NIAID. B.10...”Obter o texto integral
Artigo
2
Publicado no Mol Cell Proteomics
(2017)
“... in the development of new small-molecule therapeutics. Knowing a compound's targets and mechanism of action...”Obter o texto integral
Artigo
3
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo